US BioTek Laboratories, Inc. (“US BioTek” or the “Company”) is a leading laboratory specializing in testing for food-related allergies and intolerances. Headquartered in Shoreline, Washington, US BioTek’s testing facility provides a variety of immunology and chemistry profiles to naturopaths, clinics, and physicians around the world.
Zachary Scott was retained on an exclusive basis to represent the shareholders in their search for a partner that would further advance the growth and success of the business while allowing the owners to move into advisory roles.
Zachary Scott organized a competitive sale process that attracted a range of bids from industry participants and qualified financial buyers. The sale of the Company was consummated with Pike Street Capital, a private equity firm based in Seattle, Washington. Pike Street Capital’s investment and partnership will help US BioTek expand its testing services and reach a growing global customer base.